[PR Newswire] – ABBOTT PARK, Ill., July 20, 2016 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2016. Second-quarter worldwide sales of $5.3 billion increased … Read more on this. , valued at $recting to http://finance.ya, ended session yesterday at $. Looking at today’s market, ABT one day range is $ and has traded between $ over the past 12 months. Priced at x this year’s forecasted earnings, ABT shares are relatively inexpensive compared to the industry’s x forward p/e ratio. Consensus earnings for the current quarter by the 0 sell-side analysts covering the stock is an estimate of $ per share, which would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. The full-year EPS estimate is $, which would be a $0.00 better than last year. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $0.00 . If realized, that would be a 0.00% decrease over the year-ago quarter. Recently, d ABT from to (/fi). Previously, d ABT from to . The average price target for ABT shares is $, which is 0.00% below where the stock opened this morning. See more in (NYSE:ABT) Similar Articles: Stock Update: Abbott Laboratories (NYSE:ABT) – Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity Company Update: Abbott Laboratories (NYSE:ABT) – Abbott Reports First-Quarter 2016 Results Stock Update: Abbott Laboratories (NYSE:ABT) – FDA advisers to weigh risks of Abbott’s dissolving stent